Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

The Zacks Consensus Estimate for TSLA's fourth-quarter earnings and revenues is pegged at 76 cents per share and $27.61 ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical ...

Snap's valuation appears egregious, with EV/EBITDA indicating it's the most expensive among peers. See here to know why we ...

Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.

The Travelers Companies TRV reported fourth-quarter 2024 core income of $9.15 per share, which beat the Zacks Consensus ...

Comerica Incorporated CMA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.2, missing the Zacks Consensus ...

For 2025, Abbott forecast organic sales growth of between 7.5% and 8.5%, as well as adjusted earnings per share of $5.05 to $5.25. Analysts expect $5.16 a share on $42 billion in sales.

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.